() OrigiMed

() , , 6 ; 6 ;;;;,, ,, The OrigiMed is a science and technology transforming company which focuses on developing new technologies and clinical translation for all cancer patients across China. By carrying out comprehensive detection via next generation high-throughput sequencing technologies, we provide personalized treatment options and consulting services for each individual cancer patient. We hold ourselves to a high-level of excellence, striving to create the maximum benefit for patients under the international standardization and quality control system

生物科技 and 医疗咨询

() origimed operates in the Biotechnology research industry.

() origimed's revenue is $55.50m

() origimed has 51 - 200 employees.